Firma

Outlook Therapeutics Inc.

geo

111 Wood Ave unit 100
NJ 08830 South Iselin (USA)

Kontaktdaten

telephone

+1 609619 3990

envelope

info@outlooktherapeutics.com

globe

www.outlooktherapeutics.com

Präparate (1)

Lytenava 25 mg/ml Injektionslösung

Bevacizumab

RL FI